Abridge builds clinical documentation AI that turns doctor-patient conversations into structured medical notes.
| date | round | amount | valuation | investors |
|---|---|---|---|---|
| Feb 2025 | Series D | $250M | $2.75B post-money | Elad Gil, IVP |
Abridge's ambient documentation produces immediate, high-quality clinical notes, creating tangible workflow savings and separating AI-forward health systems from slower adopters.